Clinical Trial Update: Rifaximin for the Secondary Prevention of Recurrent Pouchitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from the University of North Carolina is evaluating rifaximin for the secondary prevention of recurrent pouchitis and is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pouchitis

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Pouchitis | Phase 4 | Status: RECRUITING